Drug Discovery

University of Bristol researchers target the glycocalyx to prevent diabetic retinopathy and kidney disease

Diseases can affect men and women differently. We must acknowledge and accept that – and then optimize drug development accordingly

Acknowledging the shortcomings in IBD-related clinical trials and a potential holistic approach to overcoming them

It’s already used for processing powders in many industries, but here’s why pastillation should come to pharma next.

Sitting Down With Christian Baber of the Pistoia Alliance

How quantum mechanics and machine learning can be combined to develop new drugs

Academia has its appeal for many; for others the real challenges are in industry. Here, IO Biotech CEO Mai-Britt Zocca discusses her own motivations.

How a study involving Super Mario Odyssey and depression captured imaginations.

Oncology is a tricky sector in which to innovate, but we can start by optimizing existing combination approaches

Looking back on the achievements of Rosalind Franklin